Dianthus Therapeutics Banner

Event Details

Dianthus Therapeutics Announces Initiation of Phase 3 Emerge Trial of Claseprubart in Generalized Myasthenia Gravis
Press Release

Cantor 2024 Global Healthcare Conference

Sep 17, 2024 10:55 AM EDT